$1.30
-0.11-7.8%
Last update: Nov 5, 4:37 AM
PDS Biotechnology Corp
PDSBNASDAQ
The average analyst price target for PDS Biotechnology is $7.80, 514.2% above the current price. Of 5 analysts, 5 rate it Buy. Targets range from $3 to $20. The latest change came on Oct 29, 2026, when B. Riley Securities raised its price target on PDS Biotechnology from $3 to $4 and kept a Buy rating.
Price Target Range — 12 Quarters
Analyst Consensus — 5 Analysts
Rating Trend — Last 9 Months
